Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Seagen

Explore full profile

A global biotechnology company dedicated to developing revolutionary therapies with real impact

Bothell, United StatesFounded 1998Biotech & Life Sciences
Valuation $42B Market cap · 2026
Revenue $2.30B Latest reported FY

At a glance

Status
Listed
Founded
1998
Headquarters
Bothell, United States
Listing
IPO 2001
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Indosuez Ventures
  • Sofinnova Investments
  • OVP Venture Partners

Series B and later2 investors entered at this stage

  • International Biotechnology Trust
  • Scale Venture Partners

Talent

Book a demo to see the people
Employees mapped 708 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 30 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Seagen employees who went on to found companies, sorted by Dealroom signal score.

Day One BiopharmaceuticalsEst. 2018
SBSamuel BlackmanUnited States
Signal score83
OsmosesEst. 2021
Holden LaiUnited States
Signal score74
ProfoundBioEst. 2018
Baiteng ZhaoUnited States
Signal score69
Alder BiopharmaceuticalsEst. 2004
MLMark LittonUnited States
Signal score60
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States91%
🇨🇭 Switzerland2.7%
🇫🇷 France1.8%
🇩🇪 Germany0.8%
🇬🇧 United Kingdom0.6%
Top 5 of 13 shown

Patents

Estimated portfolio value
$277M

169 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Seagen was the backer or acquirer, 2015–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Seagen's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Seagen's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Seagen on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Seagen on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles